🇬🇧
← Назад к новостям

Amwell (NYSE: AMWL) Q2 2026 Earnings: Telehealth Company Shows Financial Improvement

Перевод этой статьи ещё готовится — ниже оригинал на английском.

  • Amwell reported an improved EPS of -$0.59, significantly beating the consensus estimate of -$0.86 and showing a strong recovery from the -$1.24 loss in the prior year.
  • The company's quarterly revenue of $52.05 million surpassed expectations, with subscription revenue now forming a stable majority at $25.7 million.
  • Amwell strengthened its financial position by narrowing its operating loss by 53% to $9.6 million, ending the quarter with $196 million in cash and no debt, and aiming for operational and cash flow break-even by Q4.

American Well Corporation (NYSE: AMWL), which operates as Amwell, is a telehealth company. It provides a technology platform that enables virtual medical care for health systems, health plans, and employers. The company is shifting its strategy from being a simple telehealth vendor to providing the core infrastructure for AI-powered healthcare programs.

On August 4, 2026, Amwell reported its second-quarter financial results. The company announced an earnings per share (EPS) of -$0.59. This figure was better than the market's consensus estimate of -$0.86. EPS shows a company's profit per share of stock; a negative number like this indicates a net loss for the period.

As highlighted by Zacks, this EPS result is a significant improvement from the -$1.24 per share loss reported in the same quarter one year ago. Amwell also announced quarterly revenue of $52.05 million. This figure surpassed the consensus estimate of $49.87 million, resulting in a positive revenue surprise of 3.84% for the quarter.

While the revenue beat estimates, the $52.05 million figure represents a 26.6% decrease from the $70.9 million reported in the prior year's quarter. The company notes that subscription revenue now accounts for $25.7 million. This is more than half of its total revenue and creates a more stable business foundation.

Amwell is also improving its financial position. It narrowed its operating loss by 53% year-over-year to $9.6 million and ended the quarter with $196 million in cash and no debt. The company raised its profitability outlook, aiming to break even on operations and cash flow in the fourth quarter.

Материалы новостей предоставлены сторонними источниками и не являются инвестиционной рекомендацией.